Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis
X Feng, S Li, Q Sun, J Zhu, B Chen, M Xiong… - Frontiers in …, 2020 - frontiersin.org
Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …
spreading on a global scale and poses a great threat to human health. Acute respiratory …
[HTML][HTML] Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira… - Advances in …, 2020 - SciELO Brasil
The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
CoV-2) has become a global major concern. In this review, we addressed a theoretical …
Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications
The present is a comprehensive review of the immunopathology of Covid-19. The immune
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
reaction to SARS-CoV-2 infection is characterized by differentiation and proliferation of a …
[HTML][HTML] SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
G di Mauro, C Scavone, C Rafaniello, F Rossi… - International …, 2020 - Elsevier
The new coronavirus outbreak is an ongoing pandemic that is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus SARS-Cov-2 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The new coronavirus SARS-Cov-2 …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Hyperinflammatory response in COVID-19: a systematic review
MJA Silva, LR Ribeiro, MIM Gouveia, BR Marcelino… - Viruses, 2023 - mdpi.com
COVID-19 is a multisystemic disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
coronavirus 2 (SARS-CoV-2). The immunopathogenic conditions of the hyperinflammatory …
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
A Alunno, A Najm, X Mariette, G De Marco… - Annals of the …, 2021 - ard.bmj.com
Objective To summarise the available information on efficacy and safety of
immunomodulatory agents in SARS-CoV-2 infection. Methods As part of a European …
immunomodulatory agents in SARS-CoV-2 infection. Methods As part of a European …
Treatment algorithm for COVID-19: a multidisciplinary point of view
F Galluccio, T Ergonenc, A Garcia Martos… - Clinical …, 2020 - Springer
Abstract The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December
to the end of March, to 185 countries, and there have been over 3,000,000 cases identified …
to the end of March, to 185 countries, and there have been over 3,000,000 cases identified …
Managing rheumatoid arthritis during COVID-19
R Roongta, A Ghosh - Clinical rheumatology, 2020 - Springer
The outbreak of coronavirus in the world has led to an uncertainty about treatment of
patients with autoimmune disorders because of their weakened immune system coupled …
patients with autoimmune disorders because of their weakened immune system coupled …
[HTML][HTML] The role of Interleukin 6 inhibitors in therapy of severe COVID-19
E Nasonov, M Samsonov - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …